Abstract
Introduction In achieving sustainable development goal 3.1, Tanzania needs substantial investment to address the persistent burden of maternal mortality. Efforts are needed to curtail the three delays which underlie most of the deaths. The government of Tanzania implemented a community-based emergency transport intervention to address the second delay through m-mama program to address these delays. This examined the cost-effectiveness of this intervention as compared to the use of a standard ambulance system alone.
Materials and Methods Program data provided by the program implementers was used in this secondary data analysis. The data included costs of referral services using the Emergency Transportation System (EmTS) and comparing with the standard ambulance system. Analysis was conducted using Microsoft Excel to generate data that was fed in a TreeAge Pro Healthcare 2022 model. The cost and effectiveness data were discounted at 5% to make fair comparisons of the two systems.
Results A total of 989 referrals were made where, 30.1% were completed using the standard referral system using ambulance, and the majority (69.9%) were completed using the EmTS. The Emergency transport system costed USD 170.4 per completed referral compared to USD 472 per referral using ambulance system alone in the six councils of Shinyanga region where the intervention was conducted.
Conclusion The introduction of m-mama emergency transportation system has proved to be cost effective compared to the use of standard ambulance system alone in Shinyanga region. Given the high burden of maternal mortality in Tanzania, this community-based program can save implementation costs and may be more sustainable should be scaled up to other regions in Tanzania. Using implementation science methods while scaling up, lessons learned in various regions may further improve the effectiveness of the EmTS.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by Vodafone and Grand Challenge Canada. LD was the awardee. Both funders had neither role nor influence on the evaluation design, data analysis, decision to publish, preparation of the manuscript and the results presented.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The evaluation protocol was submitted to and approved by the Muhimbili University of Health and Allied Sciences (MUHAS) - Institutional Review Board (IRB). Written Informed consent was obtained for participants who participated in the interviews during the evaluation.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Not Applicable
Footnotes
Email Addresses GM: mgilbert098{at}gmail.com
LM: lindasozy{at}gmail.com
BJN: bellyjacky25{at}gmail.com
JEN: jacklinengowi64{at}gmail.com
JTK: jtkengia{at}yahoo.com
NAK: nkapologwe2002{at}gmail.com
LD: ldeng{at}touchfoundation.org
AT: atimbrell{at}touchfoundation.org
WK: wkitinya{at}touchfoundation.org
ABP: andreapembe{at}yahoo.co.uk
BS: sunguya{at}gmail.com
Data Availability
Since the authors were external evaluators of the implementation of m-Mama program they legally do not own the data, they had limited access during the evaluation period and thus would like to request a waiver on making the data publicly available. Moreover, the data sharing procedure requires signing a Data Transfer Agreement through the National Research and Ethics Committe, a lengthy process that requires amending the consent, which may be difficult since it was not indicated while collecting data, but can always share any analyses required by reviewers or editors.
